This site is intended for Healthcare Professionals only.

Search here...

Tag: Medicines and Healthcare products Regulatory Agency; MHRA; drugs stability testing; USV UK Limited; Olopatadine

New cancer treatment approved by MHRA for stomach and gastro-oesophageal junction cancer

News rudra mulmule rudra mulmule -
The most common serious side effects of the newly approved zolbetuximab by MHRA include nausea, vomiting, and hypersensitivity reactions A new cancer treatment for adults...

Class 2 recall for Olopatadine eye drops

News PB Staff Writer PB Staff Writer -
The Medicines and Healthcare products Regulatory Agency has issued a class 2 medicines recall notice for Olopatadine USV 1mg/ml eye drops. Specific batches of this product...

Follow us

Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy

Company

Latest news

Pharmacist to give evidence at Covid-19 Inquiry for the first time

News 0
The NPA has already submitted several statements in different...

Pharmacist Support launches 2024 ACTNow Campaign

News 0
The charity encourages pharmacists to join the three-week campaign to...

Alliance Healthcare UK raises over £30,000 for charity at Sports & Family Fun Day

News 0
Participating in various events throughout the year, Alliance Healthcare...

Popular news

EXCLUSIVE – Andrew Lane: Empowering pharmacy contactors

BIG INTERVIEW 0
After two days of intense deliberation on the future...

NHS to address workforce shortage by recruiting 2,000 doctors from India

News 0
The shortage of doctors in the country is attributed...

LloydsPharmacy confirms exit from the high street

News 0
The chain has closed four stores and sold all...

Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc

This site is intended for Healthcare Professionals only.